Scotiabank Maintains Sector Outperform on Aura Biosciences, Raises Price Target to $23
Portfolio Pulse from Benzinga Newsdesk
Scotiabank analyst George Farmer has maintained a Sector Outperform rating on Aura Biosciences and raised the price target from $20 to $23.
October 18, 2024 | 3:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Scotiabank has maintained its Sector Outperform rating on Aura Biosciences and increased the price target from $20 to $23, indicating a positive outlook.
The increase in price target from $20 to $23 by Scotiabank suggests a positive outlook for Aura Biosciences. The maintained Sector Outperform rating indicates confidence in the company's performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100